Wambolt & Associates’s Clorox CLX Stock Holding History

Wambolt & Associates’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,131	Closed	-$202K	–	247
2021 Q2	$202K	Buy	+1,131	New	+$206K	0.09%	237
2021 Q1	–	Sell	-1,055	Closed	-$213K	–	216
2020 Q4	$213K	Buy	+1,055	New	+$218K	0.13%	193

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wambolt & Associates's CLX Position: Q3 2021 in Review

Wambolt & Associates sold out of Clorox (CLX) in Q3 2021, closing a stake of 1,131 shares — an estimated $202K sold.

Wambolt & Associates first reported a position in CLX in Q4 2020 and held it in 2 quarters. The position peaked at $213K in Q4 2020. 1,134 funds tracked by Wall St. Rank hold CLX as of Q3 2021.

Wambolt & Associates reported no remaining Clorox position as of Q3 2021 after selling out during the quarter.
Wambolt & Associates sold 1,131 Clorox shares in Q3 2021, an estimated $202K.
Wambolt & Associates first reported a position in Clorox in Q4 2020 and held it in 2 quarters.
Wambolt & Associates's Clorox position peaked at $213K in Q4 2020.
1,134 funds tracked by Wall St. Rank held Clorox as of Q3 2021.

Based on Wambolt & Associates's 13F filing for Q3 2021, filed 20 Oct 2021.